{"organizations": [], "uuid": "8b0bb28b5ee74f078a466129d1eba980e12920d1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://www.reuters.com/finance/personal-finance", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "http://www.reuters.com/article/2015/07/30/astrazeneca-results-idUSWLB008Y520150730", "country": "US", "title": "BRIEF-AstraZeneca CEO says prices for acquisitions these days pretty hefty", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "BRIEF-AstraZeneca CEO says prices for acquisitions these days pretty hefty | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-07-30T16:40:00.000+03:00", "replies_count": 0, "uuid": "8b0bb28b5ee74f078a466129d1eba980e12920d1"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/07/30/astrazeneca-results-idUSWLB008Y520150730", "ord_in_thread": 0, "title": "BRIEF-AstraZeneca CEO says prices for acquisitions these days pretty hefty", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "July 30 AstraZeneca PLC CEO Pascal Soriot told analysts: * CEO says looking at deals but prices for acquisitions these days are \"pretty\nhefty\" * CEO says he never said in December 2014 interview that long-term target of\n$45 billion sales by 2023 was difficult to hit * For more news, please click here", "external_links": [], "published": "2015-07-30T16:40:00.000+03:00", "crawled": "2015-07-30T15:50:47.420+03:00", "highlightTitle": ""}